Kinga Bora
A First‑in‑Class Blood‑Stage Malaria Vaccine

Kingabora was founded by a team of experienced malaria researchers, public health experts from the Swiss Tropical and Public Health Institute (Swiss TPH), vaccine developers and biotech entrepreneurs- it's mission is to develop next-generation malaria vaccines designed to address and overcome key limitations of current vaccination strategies. The objective is to provide effective protection for both children and adults in low- and middle-income countries as well as in industrialized, high-income countries.







This site is currently under construction.
Don't hesitate, visit it very soon!